Lupus Unlocked: Journal Club
In this first webinar of RheumNow's Lupus Unlocked campaign, we'll be discussing these two articles: Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis. Furie R, et al. NEJM. 2025 Feb 7. doi: 10.1056 Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1) Rovin BH. Lancet. 2021 May 29;397(10289) Speakers: Brad Rovin, MD Richard Furie, MD Jack Cush, MD Discussion followed by live Q & A
▶︎
Journal Club: Voclosporin for Lupus Nephritis: Efficacy & Safety Insights from AURORA 1 & 2 Trials
▶︎
Obinutuzumab in Lupus Nephritis - REGENCY - Prof. Dr. Brad Rovin, Prof. Dr. Ana Malvar
▶︎
RheumNow EULAR 2026 Rheumatology Round Up
▶︎
Baim Grand Rounds Manesh Patel 08Jun2026
▶︎
Advances in Lupus Nephritis
▶︎
Oncology Grand Rounds: Biomarker Treatment Strategies & Emerging Therapeutic Targets - June 8, 2026
▶︎
Lupus Nephritis with Fahmeedah Kamal, MD
▶︎
Female-Specific Exercise & Nutrition for Health, Performance & Longevity | Dr. Stacy Sims
▶︎
2026 GRAPPA Virtual Congress Highlights EULAR
▶︎
KDIGO 2024 Guideline on Lupus Nephritis (LN): A Roundtable Discussion
▶︎
New Hope for Treating Kidney Lupus (Lupus Nephritis) - A webinar with Dr. Janet Pope
▶︎
EULAR 2026 RA Topic Panel
▶︎
Update on Lupus Clinical Trials 2026
▶︎
Rocky Mountain Highlights 2023 | Session II - High Yield Topics in Hepatology
▶︎
EULAR 2026 Rheumatology Round Up
▶︎
REGENCY: Obinutuzumab’s Promise for Lupus Nephritis
▶︎
Modern Strategies for Managing Sleep Apnea (Atul Malhotra, MD)
▶︎
2025 #LastestOnLupus Conference: "New Insights in Lupus & Kidney Health" with Lupus LA & UCI
▶︎
Baim Grand Rounds Katherine Tuttle 15Jun2026
▶︎